Sangamo Therapeutics
SGMO
#8725
Rank
NZ$0.28 B
Marketcap
NZ$0.86
Share price
-6.45%
Change (1 day)
-74.37%
Change (1 year)

Sangamo Therapeutics (SGMO) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$0.14 Billion

According to Sangamo Therapeutics 's latest financial reports the company's total liabilities are NZ$0.14 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Sangamo Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$0.13 B7.28%
2023-12-31NZ$0.13 B-69.07%
2022-12-31NZ$0.42 B-16.95%
2021-12-31NZ$0.50 B-17.02%
2020-12-31NZ$0.61 B101.1%
2019-12-31NZ$0.30 B-8.6%
2018-12-31NZ$0.33 B139.03%
2017-12-31NZ$0.13 B344.34%
2016-12-31NZ$31.32 M-13.55%
2015-12-31NZ$36.22 M-22.4%
2014-12-31NZ$46.68 M100.57%
2013-12-31NZ$23.27 M8.57%
2012-12-31NZ$21.43 M132.27%
2011-12-31NZ$9.23 M0.41%
2010-12-31NZ$9.19 M-57.36%
2009-12-31NZ$21.55 M0.45%
2008-12-31NZ$21.46 M39.57%
2007-12-31NZ$15.37 M53.11%
2006-12-31NZ$10.04 M-38.54%
2005-12-31NZ$16.34 M396.6%
2004-12-31NZ$3.29 M36.16%
2003-12-31NZ$2.41 M-36.15%
2002-12-31NZ$3.78 M-41.09%
2001-12-31NZ$6.42 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Gilead Sciences
GILD
NZ$64.18 B 44,896.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$7.99 B 5,504.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$139.38 B 97,620.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$19.04 B 13,249.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
NZ$72.57 B 50,781.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$196.53 B 137,690.05%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$2.69 B 1,790.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$134.39 B 94,122.09%๐Ÿ‡บ๐Ÿ‡ธ USA